Godefrooij Daniel A, Boom Kim, Soeters Nienke, Imhof Saskia M, Wisse Robert P L
Utrecht Cornea Research Group, Department of Ophthalmology, University Medical Center Utrecht, Office E03.136, PO Box 85500, 3508 GA, Utrecht, The Netherlands.
Int Ophthalmol. 2017 Apr;37(2):341-348. doi: 10.1007/s10792-016-0262-z. Epub 2016 May 24.
Previous research suggested that baseline corrected distance visual acuity (CDVA) and maximum keratometry (Kmax) are the predictors for effectiveness of corneal crosslinking (CXL) for keratoconus. The aim of this study was to validate the previously determined predictors in a new treatment cohort. A prospective cohort of 112 eyes in 90 consecutive patients was used to validate the results of 102 eyes in 79 patients from our previous prospective cohort. All patients were treated using epithelium-off corneal CXL in a tertiary hospital setting. Primary outcomes were changes in CDVA (LogMAR) and Kmax between baseline and 1-year post-treatment. Predictive factors for both outcomes were determined using univariable and multivariable analyses. Lower pretreatment CDVA was found to be the sole independent factor predicting an improvement in CDVA 1 year after CXL (β coefficient: -0.476, P < 0.01). Kmax flattening is more likely to take place in eyes with preoperative central cones (β coefficient: 0.655, P < 0.01). These results are consistent with our initial research and indicate high reproducibility in the new cohort. The previously postulated prediction model for postoperative CDVA showed limited predictive value in the validation cohort (R = 0.15). The clinical implication of these results is that patients with lower pretreatment visual acuity are more likely to benefit from CXL (with respect to visual acuity), and patients with more central cones will benefit more in terms of cone flattening. Furthermore, those results can be used to guide customization of the crosslinking treatment.
先前的研究表明,基线校正后的远视力(CDVA)和最大角膜曲率(Kmax)是圆锥角膜交联术(CXL)疗效的预测指标。本研究的目的是在一个新的治疗队列中验证先前确定的预测指标。对90例连续患者的112只眼进行前瞻性队列研究,以验证我们先前前瞻性队列中79例患者的102只眼的研究结果。所有患者均在三级医院环境中接受去上皮角膜交联术治疗。主要观察指标为基线和治疗后1年时CDVA(LogMAR)和Kmax的变化。使用单变量和多变量分析确定两个观察指标的预测因素。发现较低的治疗前CDVA是预测CXL术后1年CDVA改善的唯一独立因素(β系数:-0.476,P <0.01)。术前中央圆锥角膜的眼睛更有可能发生Kmax变平(β系数:0.655,P <0.01)。这些结果与我们最初的研究一致,表明在新队列中有很高的可重复性。先前假设的术后CDVA预测模型在验证队列中的预测价值有限(R = 0.15)。这些结果的临床意义在于,治疗前视力较低的患者更有可能从CXL(在视力方面)中获益,而中央圆锥角膜较多的患者在圆锥角膜变平方面将获益更多。此外,这些结果可用于指导交联治疗的定制。